Toyoshi Hosokawa
Overview
Explore the profile of Toyoshi Hosokawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M, Yamaguchi Y, et al.
J Pain Res
. 2018 Oct;
11:2197-2206.
PMID: 30323654
Purpose: Predictive value and accuracy of the acute pain trajectory were compared with those of pain intensity at 1 day after the surgery for pain prevalence at 6 months after...
2.
Sumitani M, Sakai T, Matsuda Y, Abe H, Yamaguchi S, Hosokawa T, et al.
J Anesth
. 2018 May;
32(3):463-478.
PMID: 29737410
Neuropathic pain has a substantial effect on quality of life (QOL). The Japanese Society of Pain Clinicians (JSPC) has developed clinical guidelines of pharmacotherapy for neuropathic pain. These guidelines offer...
3.
Kanbayashi Y, Ishikawa T, Kanazawa M, Nakajima Y, Tabuchi Y, Kawano R, et al.
Med Oncol
. 2018 Apr;
35(6):82.
PMID: 29705823
Cholinergic syndrome is an acute adverse reaction associated with irinotecan. Development of cholinergic syndrome can be ameliorated or prevented by administering various anticholinergics, including atropine sulfate or scopolamine butylbromide. Although...
4.
Kanbayashi Y, Ishikawa T, Kanazawa M, Nakajima Y, Kawano R, Tabuchi Y, et al.
Med Oncol
. 2018 Mar;
35(4):55.
PMID: 29549536
Although pegfilgrastim prophylaxis is expected to maintain the relative dose intensity (RDI) of chemotherapy and improve safety, information is limited. However, the optimal selection of patients eligible for pegfilgrastim prophylaxis...
5.
Fujimoto S, Iwawaki Y, Takishita Y, Yamamoto Y, Murota M, Yoshioka S, et al.
Jpn J Clin Oncol
. 2017 Oct;
47(11):1066-1072.
PMID: 28973425
Objective: In palliative care hospitals in Japan, mechanical bathing is conducted to maintain cleanliness. However, the physiological and psychological influence of mechanical bathing on patients has not been sufficiently studied....
6.
Taniguchi A, Fukazawa K, Hosokawa T
J Palliat Med
. 2017 Aug;
20(10):1171-1174.
PMID: 28772087
Background: Medication-related osteonecrosis of the jaw (MRONJ) is an important complication in patients treated with antiresorptive agents such as bisphosphonates and the receptor activator of nuclear factor κB ligand inhibitor...
7.
Kanbayashi Y, Inagaki M, Ueno H, Hosokawa T
Med Oncol
. 2017 Jul;
34(8):137.
PMID: 28687964
Duloxetine is an effective therapeutic agent for chemotherapy-induced peripheral neuropathy (CIPN). However, predictors of duloxetine response have not been adequately explored. Therefore, this retrospective study was performed to identify predictive...
8.
Hatano Y, Mitsuki S, Hosokawa T, Fukui K
J Cancer Educ
. 2017 Feb;
33(1):208-213.
PMID: 28168683
Cancer survivors face many challenges, and cancer support groups provide a range of support. Several reports have shown the benefits of support groups. However, it is not clear how Japanese...
9.
Kanbayashi Y, Hosokawa T
Clin Drug Investig
. 2017 Jan;
37(4):387-392.
PMID: 28101697
Background And Objectives: Although some studies have examined the use of corticosteroids, their effectiveness in treating cancer-related fatigue (CRF) has yet to be established. Therefore, this retrospective study attempted to...
10.
Kanbayashi Y, Matsumoto Y, Kuroda J, Kobayashi T, Horiike S, Hosokawa T, et al.
Ann Hematol
. 2016 Nov;
96(2):311-315.
PMID: 27896415
To identify risk factors for varicella zoster virus (VZV) infection and postherpetic neuralgia (PHN) after hematopoietic cell transplantation (HCT), we conducted a retrospective chart review of 163 consecutive patients who...